Centre directs states, UTs to enforce ban on reuse of single-use medical devices

The Centre has directed every state and Union Territory to strictly enforce a ban on reusing medical devices marked for one-time use. The ban applies to public and private healthcare organisations. It also covers disposable surgical items. The goal is to reduce infection risks, protect patients and ensure hospitals follow medical-device rules.

The devices must be used according to the instructions of the original equipment manufacturer. Examples include cardiac catheters, dialysis equipment, surgical staplers, laparoscopic trocars, syringes and needles. The DGHS reported that some hospitals were sterilising these products after one procedure and using them again.

State authorities, health officials, drug controllers and the DCGI have been asked to monitor compliance. They must inspect healthcare establishments and act against violations. The directive also addresses concerns that patients or government schemes were sometimes charged the full price for equipment that had already been reused.

A single-use medical device is a product intended by its manufacturer for one use or one procedure. After that use, it is supposed to be discarded according to applicable biomedical-waste requirements. Its design, materials and performance limits are not intended to support repeated processing.

Equipment designed for repeated use is different because its manufacturer provides instructions for cleaning, sterilisation, inspection and reuse. Those instructions may specify how the equipment should be handled and when it must be removed from service. The source article specifically requires single-use items to follow the original equipment manufacturer's instructions.

This distinction matters because sterilising an item does not automatically change its intended use. Reusing a single-use device can leave biological material behind or damage its function. The article reports that such reuse may cause infection, malfunction, reduced performance and other procedure-related complications.

The article names ten device or disposable-item types reportedly being reused when dialysers and blood tubing are counted separately. They are cardiac catheters, guidewires, balloon catheters, ablation catheters, introducer sheaths, dialysers, blood tubing, surgical staplers, laparoscopic trocars, and orthopaedic drill bits. AiMeD also identifies syringes and needles as reused items.

The practice is reported particularly in cardiology, nephrology, oncology, cardiothoracic and vascular surgery, and neurosurgery. These specialties often involve invasive procedures, so device safety and infection control are especially important. The source does not provide a numerical total of hospitals or reused devices.

The list shows that reuse is not limited to one kind of equipment. It includes catheters, dialysis supplies, surgical tools and injection items. The Centre’s directive therefore applies broadly across healthcare facilities, rather than targeting one specialty or one product category.

Sterilisation does not guarantee that a single-use device becomes safe for another patient. The DGHS said reprocessing may be inadequate, allowing biological material to remain. A device can also deteriorate after its first use. These problems may not be visible, but they can affect safety during a later procedure.

For example, a cardiac catheter, dialysis component or surgical tool may be exposed to blood or other biological material during its first use. If cleaning or sterilisation is incomplete, material can remain. If the device has weakened or changed shape, it may also work less reliably. The article warns that both problems can matter even after sterilisation.

The concern is therefore wider than infection alone. Reprocessing may fail to control contamination, while repeated use may reduce performance or cause malfunction. The DGHS has instructed facilities to use single-use devices strictly according to the original equipment manufacturer’s instructions and not reuse them.

Reuse can expose patients to cross-infections when biological material or infectious contamination remains on a device. The DGHS specifically warned about hepatitis B, hepatitis C, HIV and bacterial infections. This makes the issue a direct patient-safety concern, not merely a hospital-management problem.

The danger can also come from the device itself. Reprocessing may damage or weaken equipment, causing malfunction or reduced performance during a procedure. Cardiac catheters, guidewires, dialysis equipment, surgical staplers and other items may not work as intended after reuse. The article also mentions other procedure-related complications.

These risks can overlap. A contaminated device may transmit infection, while a damaged device may fail during treatment. The Centre has therefore ordered a strict prohibition in public and private facilities. Inspections, monitoring and action against violations are intended to prevent unsafe reuse and protect patients.

Charging the full price for a reused device raises a healthcare-cost concern because patients may pay as though they received new equipment. The DGHS also reported cases in which government authorities reimbursed the full cost. The financial charge therefore may not match what was actually supplied or used.

The article links this practice to alleged reuse in private and corporate hospitals. A patient could face the infection and performance risks of reused equipment while being billed for a single-use item. The concern is especially serious when the device is used in a critical procedure or when the cost is covered by a public scheme.

The practice also raises regulatory questions. The DGHS said reuse may violate the Drugs and Cosmetics Act, Medical Devices Rules, Clinical Establishments Act and infection-control requirements. Authorities have been told to inspect facilities, monitor compliance and take action against violations, alongside enforcing the reuse ban.

Sterilisation and infection prevention work together to reduce contamination during healthcare procedures. But sterilisation must be suitable for the equipment, and single-use items must not be reused merely because they were processed. The DGHS warned that inadequate reprocessing can leave biological material behind and expose patients to infection.

Medical-device regulation defines how products should be used, while infection-control requirements guide safe handling in healthcare facilities. Biomedical-waste management provides the route for discarding items after use instead of sending them back into procedures. Together, these safeguards cover use, processing, monitoring and disposal.

The article says reuse could violate the Drugs and Cosmetics Act, Medical Devices Rules, Clinical Establishments Act and applicable infection-prevention and biomedical-waste requirements. States, Union Territories, drug controllers and health authorities must enforce the ban. Facilities must follow original equipment manufacturer instructions and face action for violations.